Yoni K. Ashar, PhD; Alan Gordon, LCSW; Howard Schubiner, MD; et al.
open access
has active quiz
JAMA Psychiatry. 2022;79(1):13-23. doi:10.1001/jamapsychiatry.2021.2669
This randomized clinical trial tests whether pain reprocessing therapy can provide durable and substantial relief from chronic back pain and investigates treatment mechanisms.
Ira R. Katz, MD, PhD; Malcolm P. Rogers, MD; Robert Lew, PhD; et al.
free access
has audio
JAMA Psychiatry. 2022;79(1):24-32. doi:10.1001/jamapsychiatry.2021.3170
This randomized clinical trial assesses whether the addition of lithium to existing medication regimens would prevent or delay repeated suicide-related events and whether it could be used safely.
-
Podcast:
Lithium for Suicide-Related Outcome Prevention in Veterans With Major Depression or Bipolar Disorder
Michael R. Irwin, MD; Carmen Carrillo, MA, MHS; Nina Sadeghi, BS; et al.
open access
JAMA Psychiatry. 2022;79(1):33-41. doi:10.1001/jamapsychiatry.2021.3422
This randomized clinical trial of adults without depression but with insomnia assesses whether insomnia treatment can prevent depression.
Amelia J. Scott, PhD; Louise Sharpe, PhD; Veronica Quinn, PhD; et al.
free access
JAMA Psychiatry. 2022;79(1):42-49. doi:10.1001/jamapsychiatry.2021.3204
This meta-analysis of 347 trials examines the association of the use of placebo run-in periods with the placebo response, drug response, and drug-placebo difference among randomized clinical trials of antidepressants.
Angélica Meinhofer, PhD; Jesse M. Hinde, PhD; Katherine M. Keyes, PhD, MPH; et al.
free access
JAMA Psychiatry. 2022;79(1):50-58. doi:10.1001/jamapsychiatry.2021.3193
This cross-sectional study examines the prevalence of co-occurring psychiatric and medical conditions in prenatal hospitalizations of individuals with and without cannabis use disorder by concomitant substance use disorders.
Xabier Calle Sánchez, MS; Dorte Helenius, PhD; Jonas Bybjerg-Grauholm, PhD; et al.
free access
JAMA Psychiatry. 2022;79(1):59-69. doi:10.1001/jamapsychiatry.2021.3392
This cohort study examines the prevalence and penetrance of copy number variants across the major recurrent copy number variants that are associated with risk for psychiatric disorders.